Proprietary AI analyst is now available
- Public Comps
- Provectus
Provectus Valuation Multiples
Discover Provectus' revenue and EBITDA valuation multiples and M&A history, alongside public comparables like Helport AI, Substrate Artificial, Insig AI, Satsuma Technology and more.
Provectus Overview
About Provectus
Provectus Biopharmaceuticals Inc is a clinical-stage biotechnology company developing immunotherapy medicines for different diseases that are based on a class of synthetic small molecule immuno-catalysts called halogenated xanthenes (HXs). Its HX molecule is named rose bengal sodium. The company’s proprietary, patented, pharmaceutical-grade RBS is the active pharmaceutical ingredient in the drug product candidates of its current clinical development programs and the preclinical formulations of its current drug discovery programs.
Founded
2002
HQ

Employees
6
Website
Financials (FY)
EV
$30M
Valuation Multiples
Start free trialProvectus Financials
Provectus reported last fiscal year revenue of - and negative EBITDA of ($5M).
In the same fiscal year, Provectus generated ($5M) in EBITDA losses and had net loss of ($6M).
Provectus P&L
In the most recent fiscal year, Provectus reported revenue of - and EBITDA of ($5M).
Provectus is unprofitable as of last fiscal year, with EBITDA margin of - and net margin of -.
Financial data powered by Morningstar, Inc.
Provectus Stock Performance
Provectus has current market cap of $28M, and enterprise value of $30M.
Provectus' stock price is $0.07.
Provectus has an EPS (earnings per share) of $-0.01.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $30M | $28M | 6.6% | - | - | - | $-0.01 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialProvectus Valuation Multiples
Provectus trades at (5.7x) EV/EBITDA.
Provectus Financial Valuation Multiples
As of June 24, 2026, Provectus has market cap of $28M and EV of $30M.
Provectus has a P/E ratio of (5.0x).
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Provectus Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Provectus Margins & Growth Rates
Provectus Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Provectus Operational KPIs
Provectus' revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $0.9M for the same period.
Data powered by FactSet, Inc. and Morningstar, Inc.
Provectus Competitors
Provectus competitors include Helport AI, Substrate Artificial, Insig AI, Satsuma Technology, Datrix, OODA AI, Rocket Doctor AI, Ayfie International, Baseig and Lighton.
Most Provectus public comparables operate across Pure-Play AI Software and Generative AI.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 0.8x | - | 3.9x | - | |||
| 1.4x | - | (5.6x) | - | |||
| 37.7x | - | (3.3x) | - | |||
| 119880.5x | - | (169.3x) | - | |||
| 2.2x | 2.3x | 18.0x | 14.4x | |||
| 4.0x | - | (1.4x) | - | |||
| 32.6x | 20.1x | (7.9x) | (9.7x) | |||
| 5.0x | - | (2.6x) | - | |||
This data is available for Pro users. Sign up to see all Provectus competitors and their valuation data. Start Free Trial | ||||||
Acquisitions by Provectus
Provectus has acquired 2 companies to date.
Last acquisition by Provectus was on June 1st 2019. Provectus acquired SQUADEX for undisclosed valuation.
Latest Acquisitions by Provectus
| Description | SQUADEX is a DevOps consultancy that transforms enterprise organizations into agile squads through automation and technology integration. Silicon Valley-focused since 2011, it accelerates time-to-market for clients in tech and finance by unifying development, operations, and security pipelines. SQUADEX deploys CI/CD, containerization with Kubernetes, and cloud migrations on AWS and Azure, serving Bay Area firms with custom infrastructure for scalable product launches. | Reinvently is a Washington, D.C.-based mobile app development agency serving startups and enterprises worldwide. Established in 2010, it provides end-to-end services including research, UI/UX design, and engineering through packages like Design My App, Build My App from Scratch, and workshops on mobile strategy and app evaluation, with a portfolio exceeding 200 apps. |
| HQ Country | ||
| HQ City | San Francisco, CA | San Francisco, CA |
| Deal Date | 1 Jun 2019 | 1 Mar 2019 |
| Valuation | undisclosed | undisclosed |
| EV/Revenue | ||
| EV/EBITDA | ||
This data is available for Pro users. Sign up to see all Provectus acquisitions and their M&A valuation multiples. Start Free Trial | ||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Provectus
| When was Provectus founded? | Provectus was founded in 2002. |
| Where is Provectus headquartered? | Provectus is headquartered in United States. |
| How many employees does Provectus have? | As of today, Provectus has over 6 employees. |
| Is Provectus publicly listed? | Yes, Provectus is a public company listed on OTCM. |
| What is the stock symbol of Provectus? | Provectus trades under PVCT ticker. |
| When did Provectus go public? | Provectus went public in 1997. |
| Who are competitors of Provectus? | Provectus main competitors include Helport AI, Substrate Artificial, Insig AI, Satsuma Technology, Datrix, OODA AI, Rocket Doctor AI, Ayfie International, Baseig, Lighton. |
| What is the current market cap of Provectus? | Provectus' current market cap is $28M. |
| Is Provectus profitable? | No, Provectus is not profitable. |
| How many companies Provectus has acquired to date? | As of June 2026, Provectus has acquired 2 companies. |
| What was the largest acquisition by Provectus? | None of the M&A deals Provectus has completed have disclosed valuations. |
| What companies Provectus acquired? | Provectus acquired SQUADEX and Reinvently. |
| In how many companies Provectus has invested to date? | Provectus hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Provectus
Lists including Provectus
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.
